In Wilm’s tumor the following leads to emergence of resistance to chemotherapy:
**Core Concept**
Wilm's tumor, a childhood kidney cancer, is often treated with chemotherapy. However, resistance to chemotherapy can emerge, leading to treatment failure. This resistance is often due to genetic alterations that affect the drug's ability to kill cancer cells.
**Why the Correct Answer is Right**
The emergence of resistance in Wilm's tumor is often associated with the activation of the ALK (anaplastic lymphoma kinase) gene. This gene is a type of tyrosine kinase that can lead to the activation of various signaling pathways, making cancer cells resistant to chemotherapy. Specifically, the ALK gene can activate the PI3K/AKT pathway, which promotes cell survival and proliferation, contributing to resistance.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not directly related to the emergence of resistance in Wilm's tumor. While genetic alterations are indeed involved, the specific mechanism is more closely related to the ALK gene.
**Option B:** This option is incorrect because the emergence of resistance in Wilm's tumor is not primarily due to mutations in the TP53 gene, although TP53 mutations can contribute to cancer development.
**Option C:** This option is incorrect because the emergence of resistance in Wilm's tumor is not primarily due to epigenetic changes. While epigenetic alterations can contribute to cancer development, the specific mechanism in Wilm's tumor is more closely related to the ALK gene.
**Clinical Pearl / High-Yield Fact**
It's essential to recognize that genetic alterations, such as the activation of the ALK gene, can lead to resistance in Wilm's tumor. This knowledge can inform treatment decisions, such as the use of targeted therapies that inhibit the ALK pathway.
**Correct Answer: A. Activation of the ALK gene.**